Skip to content
Inciteful Med

Standard of Care Treatment Options

Last updated:

Chagas disease is treated with a 30-to-60-day course of either Benznidazole or Nifurtimox. These oral antiparasitic drugs aim to clear the infection and prevent future heart or digestive damage. Treatment requires close medical supervision due to a high rate of side effects.

Key Takeaways

  • • Benznidazole and Nifurtimox are the two FDA-approved oral medications for treating Chagas disease.
  • • Standard treatment lasts for 30 to 60 days and requires strict avoidance of alcohol.
  • • Medications have a high rate of side effects, requiring regular medical monitoring of liver function and blood counts.
  • • Antiparasitic treatment is crucial for acute cases, children, and adults under 50 to prevent long-term heart and digestive damage.
  • • Antibody tests often stay positive for years after successful treatment, so doctors use PCR testing and clinical monitoring to measure success.

Deciding to start treatment for Chagas disease is a significant step. While there are only two FDA-approved drugs for treating the infection, they are powerful and require careful medical supervision. The goal of treatment is to kill the parasite (Trypanosoma cruzi), which can prevent future organ damage if caught early enough [1][2].

The Two Treatment Options

There are two medications used to treat Chagas disease. Both are taken as oral tablets for a period of 30 to 60 days [3].

  • Benznidazole (BNZ): Usually considered the first-line treatment for adults because it is generally better tolerated than the alternative [4][5].
  • Nifurtimox (NFX): Often used if a patient cannot take Benznidazole or if the first treatment must be stopped due to side effects [6].

Understanding the Side Effects

It is important to be realistic: these medications are known for having a high rate of side effects, especially in adults [7]. About 10% to 20% of adults may need to stop treatment early because of how their body reacts to the medicine [8][9].

Medication Common Side Effects Potential Severe Reactions
Benznidazole Skin rash, nausea, loss of appetite [1]. Peripheral neuropathy (tingling, numbness, or pain in hands/feet) and severe allergic skin reactions [1][10].
Nifurtimox Weight loss, nausea, vomiting, stomach pain [7][6]. Neuropsychiatric symptoms (irritability, insomnia, or tremors) and nerve pain [7].

Your doctor will monitor you closely, often ordering regular blood tests to check your liver function and blood cell counts while you are on the medication [1][11].

  • Alcohol Avoidance: You must strictly avoid alcohol while taking Benznidazole or Nifurtimox to prevent severe liver and digestive reactions.

Who Should Be Treated?

The recommendation for treatment depends largely on your age and the stage of the disease:

  • Always Treated: All acute cases (recent infections), congenital cases (babies born to infected mothers), and children under 18 [5]. Cure rates are highest in these groups [12].
  • Strongly Recommended: Adults under age 50 who are in the “silent” (indeterminate) phase, to help prevent future heart or digestive issues [1][2].
  • Individual Decision: For adults over age 50, the benefits of treatment are weighed against the higher risk of side effects.
  • Advanced Disease: If severe heart damage is already present, antiparasitic drugs may not be able to reverse the damage or stop the disease from progressing [13][14]. In these cases, treatment focuses on managing heart symptoms [14].

A Note for Women

If you are of childbearing age, it is highly recommended to complete treatment before becoming pregnant. This can virtually eliminate the risk of passing the parasite to your future children [5]. However, these medications cannot be taken during pregnancy because they may harm the developing baby.

How Do I Know If It Worked?

A common source of anxiety is follow-up testing. If you are treated during the chronic phase, your antibody tests may remain positive for years or even decades after the parasite is gone [15]. This does not necessarily mean the treatment failed. Doctors often measure “success” by ensuring the disease does not progress to damage your organs, and they may use specialized PCR tests to ensure parasite levels remain undetectable [15][3].

Frequently Asked Questions

What medications are used to treat Chagas disease?
The two standard treatments are Benznidazole and Nifurtimox. These oral antiparasitic medications are typically taken for 30 to 60 days to kill the parasite and prevent future organ damage.
Who should be treated for Chagas disease?
Treatment is always recommended for recent infections, babies born with the disease, and children under 18. It is also strongly recommended for adults under 50 who are in the silent phase before organ damage occurs.
What are the side effects of Chagas disease medications?
Side effects are common and can include skin rashes, nausea, weight loss, and peripheral neuropathy, which causes tingling or numbness in the hands and feet. Due to these risks, your doctor will closely monitor your blood counts and liver function during treatment.
Can I drink alcohol while taking Chagas disease medication?
No, you must strictly avoid alcohol while taking either Benznidazole or Nifurtimox. Combining these medications with alcohol can cause severe liver and digestive reactions.
How do I know if the Chagas disease treatment worked?
Your antibody tests may remain positive for years or decades, even after the parasite is gone. Doctors measure success by monitoring your organ health to ensure the disease doesn't progress, and they may use specialized PCR tests to confirm the parasite is undetectable.
Can I be treated for Chagas disease while pregnant?
No, you cannot take these medications during pregnancy because they may harm the developing baby. However, women of childbearing age should complete treatment before becoming pregnant to virtually eliminate the risk of passing the infection to their future children.

Questions for Your Doctor

  • • Which medication do you recommend as first-line for me, and why?
  • • What are the most common side effects I should watch for in the first two weeks of treatment?
  • • How often will you be checking my blood counts and liver function while I am on this medicine?
  • • If I have to stop the first medication due to a rash or nerve pain, can we switch to the other drug?
  • • If I already have some heart damage, what are the realistic goals for this antiparasitic treatment?
  • • How will we measure if the treatment worked, considering my antibody tests might remain positive for years?

Questions for You

  • • Are you currently pregnant or planning to become pregnant in the next few months?
  • • Do you have any existing numbness or tingling in your hands or feet?
  • • Are you prepared for a 30 to 60-day course of medication that requires strict avoidance of alcohol and close medical supervision?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Antitrypanosomal therapy for Chagas disease: A single center experience with adverse drug reactions and strategies for enhancing treatment completion.

    Reifler K, Wheelock A, Hall SM, et al.

    PLoS neglected tropical diseases 2025; (19(7)):e0013218 doi:10.1371/journal.pntd.0013218.

    PMID: 40622934
  2. 2

    Treatment of Chagas Disease in the United States.

    Meymandi S, Hernandez S, Park S, et al.

    Current treatment options in infectious diseases 2018; (10(3)):373-388 doi:10.1007/s40506-018-0170-z.

    PMID: 30220883
  3. 3

    An evaluation of benznidazole as a Chagas disease therapeutic.

    Caldas IS, Santos EG, Novaes RD

    Expert opinion on pharmacotherapy 2019; (20(15)):1797-1807 doi:10.1080/14656566.2019.1650915.

    PMID: 31456439
  4. 4

    Current drug therapy and pharmaceutical challenges for Chagas disease.

    Bermudez J, Davies C, Simonazzi A, et al.

    Acta tropica 2016; (156()):1-16.

    PMID: 26747009
  5. 5

    Chagas disease: comments on the 2018 PAHO Guidelines for diagnosis and management.

    Norman FF, López-Vélez R

    Journal of travel medicine 2019; (26(7)) doi:10.1093/jtm/taz060.

    PMID: 31407784
  6. 6

    Toxicity of nifurtimox as second-line treatment after benznidazole intolerance in patients with chronic Chagas disease: when available options fail.

    Crespillo-Andújar C, Chamorro-Tojeiro S, Norman F, et al.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2018; (24(12)):1344.e1-1344.e4 doi:10.1016/j.cmi.2018.06.006.

    PMID: 29906591
  7. 7

    Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas' disease.

    Jackson Y, Wyssa B, Chappuis F

    The Journal of antimicrobial chemotherapy 2020; (75(3)):690-696 doi:10.1093/jac/dkz473.

    PMID: 31754690
  8. 8

    Benznidazole treatment safety: the Médecins Sans Frontières experience in a large cohort of Bolivian patients with Chagas' disease.

    Sperandio da Silva GM, Mediano MFF, Hasslocher-Moreno AM, et al.

    The Journal of antimicrobial chemotherapy 2017; (72(9)):2596-2601 doi:10.1093/jac/dkx180.

    PMID: 28645201
  9. 9

    Current advances in drug discovery for Chagas disease.

    Scarim CB, Jornada DH, Chelucci RC, et al.

    European journal of medicinal chemistry 2018; (155()):824-838 doi:10.1016/j.ejmech.2018.06.040.

    PMID: 30033393
  10. 10

    Severe immune thrombocytopaenia in a patient taking benznidazole for chronic Chagas disease.

    Crespillo-Andújar C, Calbacho Robles M, Norman FF, Pérez-Molina JA

    BMJ case reports 2018; (2018()) doi:10.1136/bcr-2017-223788.

    PMID: 29588298
  11. 11

    Causality and Severity of Adverse Reactions and Biochemical Changes to Benznidazole Treatment in Patients with Chronic Chagas Disease.

    Belmino ACDC, Sousa EKS, Silva Filho JDD, et al.

    Arquivos brasileiros de cardiologia 2024; (121(8)):e20230787 doi:10.36660/abc.20230787.

    PMID: 39292117
  12. 12

    Congenital Chagas disease: current diagnostics, limitations and future perspectives.

    Messenger LA, Bern C

    Current opinion in infectious diseases 2018; (31(5)):415-421 doi:10.1097/QCO.0000000000000478.

    PMID: 30095485
  13. 13

    Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy.

    Morillo CA, Marin-Neto JA, Avezum A, et al.

    The New England journal of medicine 2015; (373(14)):1295-306 doi:10.1056/NEJMoa1507574.

    PMID: 26323937
  14. 14

    Immunomodulation and Antioxidant Activities as Possible Trypanocidal and Cardioprotective Mechanisms of Major Terpenes from Lippia alba Essential Oils in an Experimental Model of Chronic Chagas Disease.

    Espinel-Mesa DX, González Rugeles CI, Mantilla Hernández JC, et al.

    Antioxidants (Basel, Switzerland) 2021; (10(11)) doi:10.3390/antiox10111851.

    PMID: 34829722
  15. 15

    Success of benznidazole chemotherapy in chronic Trypanosoma cruzi-infected patients with a sustained negative PCR result.

    Murcia L, Carrilero B, Ferrer F, et al.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2016; (35(11)):1819-1827 doi:10.1007/s10096-016-2733-6.

    PMID: 27488437

This page provides educational information about Chagas disease treatments and medications. It does not replace professional medical advice from an infectious disease specialist or your healthcare provider.

Stay up to date

Get notified when new research about American trypanosomiasis is published.

No spam. Unsubscribe anytime.